|Feb. 2, 2012 | 6:15–6:45 p.m.|
The Interventional Management of Stroke (IMS) III TrialJoseph P. Broderick, MD, FAHA, University of Cincinnati, Cincinnati, Ohio
The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke Enhanced Regimen (The CLEAR-ER Stroke Trial): An Ongoing Phase IIb TrialArthur M. Pancioli, MD, FAHA, U Cincinnati Medical Center, Cincinnati, Ohio
Mechanical Retrieval and Recanalization of Stroke Clots Using EmbolectomyChelsea Kidwell, MD, FAHA, Georgetown University, Washington D.C.
The Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Phase 3 Clinical TrialJeffrey L. Saver, MD, FAHA, Geffen School of Medicine at UCLA, Los Angeles, Calif.
Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): Update On Long Term Follow-up (Up to 10 Years)Alice J. Sheffet, PhD, UMDNJ-New Jersey Medical Sch, Newark, N.J.
Secondary Prevention of Small Subcortical StrokesOscar Benavente, MD, University of British Columbia, Vancouver, BC, Canada
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis with Alteplase in MRI-Selected PatientsOna Wu, PhD, Massachusetts General Hospital, Boston, Mass.
A Phase II RCT of Stroke Navigators to Improve Compliance with Secondary Stroke Prevention: PROTECT DCAlexander W. Dromerick, MD, National Rehabilitation Hospital, Washington, D.C.